All In MedTech

FDA Clearance Tracker · P140026-S005

ENROUTE TRANSCAROTID STENT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 18, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140026-S005
Device name
ENROUTE TRANSCAROTID STENT SYSTEM
Applicant location
Marborough, MA
Received
Jan 31, 2017
Decided
Jul 18, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P140026

Device type

Device class
Class III

Every decision under product code NIM

FDA's approval statement

As written in FDA's record.

Approval for labeling updates to incorporate the ROADSTER Study Continued Access data.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.